Funded Tech Companies
Icosavax
Icosavax is a biopharmaceutical growth company, based in Seattle. Financial backing was provided by Sanofi-Genzyme BioVentures, Adams Street Partners and Qiming Ventures.
Company Overview
Company Name
Icosavax
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
2815 Eastlake Ave. E 300
Seattle, WA 98102
USA
Seattle, WA 98102
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
We are committed to developing safe and effective vaccines against infectious diseases that address important unmet medical needs and reduce healthcare costs. We were founded on breakthrough computationally-designed virus-like particle technology, exclusively licensed for a variety of infectious disease indications from the Institute for Protein Design at the University of Washington.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/29/2021
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Adam Simpson
Chief Medical Officer
Niranjan Kanesa-thasan
Chief Scientific Officer
Douglas Holtzman
VP - Operations
Charles Richardson
Company Investors
- Sanofi-Genzyme BioVentures
- Adams Street Partners
- Qiming Ventures (Mark McDade)
- NanoDimension
Browse more funded tech companies:
iControl Networks | icotec Medical
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs